Our current data confirm that the oncogenic MYD88 L265P mutant induces strong MYD88 aggregation, IRAK1 phosphorylation and NF-κB activation in DLBCL cells (Fig. 2 and Fig. 3). Here, NFKB1 is linked to diffuse large B-cell lymphoma.